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Graphical abstract
Summary of enterohaemorrhagic Escherichia coli O157 pathogenesis using basic symbols. The right-hand illustration shows
enterohaemorrhagic E. coli interactions with an epithelial cell.
Abstract
Escherichia coli O157 : H7 is a zoonotic diarrhoeal pathogen of worldwide importance. It belongs to a subset of Shiga toxin-
producing E. coli that can form attaching and effacing lesions on intestinal epithelia via the action of a type 3 secretion
system that injects bacterial effectors into enterocytes. Infections in humans often arise from contaminated food or direct
environmental exposure and can involve life-threatening Shiga toxin-dependent sequelae. In the three decades since E. coli
O157 : H7 was first recognized intensive research has helped to unravel the basis of pathogenesis, but few effective options
for prevention and treatment of infections exist.
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TAXONOMY
Domain Bacteria, phylum Proteobacteria, class Gammapro-
teobacteria, order Enterobacteriales, family Enterobacteri-
aceae, genus Escherichia, species E. coli, serotype O157 : H7.
PROPERTIES
E. coli O157 : H7 is a chemoorganotrophic facultative anaer-
obe with both respiratory and fermentative metabolism
identified by biochemical tests and selective/chromogenic
media. Cells are Gram-negative straight rods about
1 µm2–6 µm and typically motile via peritrichous flagella.
The enterohaemorrhagic E. coli (EHEC) pathotype describes
strains that can express a type 3 secretion system (T3SS)
and produce Shiga toxin subtypes (Stx 1a, 2a, 2c, etc.),
although the original definition also required an association
with human disease [1]. Different EHEC serotypes are asso-
ciated with severe human disease but O157 : H7 is the most
prevalent in North and South America and the UK.
GENOME
EDL933 was the first O157 strain to be sequenced with a
5.4Mb chromosome encoding 1.34Mb (1387 genes) in 177
‘O-islands’ which were not present in the laboratory-
adapted E. coli K-12 strain MG1655, although the strains
share 4.1Mb of highly homologous DNA [2]. The majority
of E. coli O157 : H7 isolates also contain a 92 kb plasmid.
Lambdoid bacteriophages, integrative elements and plas-
mids have introduced the same or similar genes into diverse
serotypes that have distinct evolutionary histories, indicat-
ing parallel evolution of EHEC by independent acquisition
of mobile elements. Sequencing of E. coli O157 :H7 cata-
lysed our understanding of the vast diversity that can exist
in the ‘accessory genome’, with just 39.2% of non-redun-
dant proteins shared by EDL933, MG1655 and uropatho-
genic E. coli CFT703. The most recent evidence, based on
analysis of over 1000 E. coli O157 : H7 genomes, is that the
more recent acquisition of Stx2a prophages was critical to
emergence of EHEC O157 : H7 as a life-threatening zoo-
notic pathogen in the last few decades [3]. Machine-learning
approaches applied to whole-genome sequences indicate
that only a minority of E. coli O157 : H7 isolates may have
zoonotic potential with prophage variation being critical to
this capacity [4].
PHYLOGENY
Evidence supports evolution of E. coli O157 : H7 from a
non-toxigenic EPEC O55 :H7 by acquisition of Stx2c-
encoding prophage followed by the pO157 plasmid and the
switch to the O157 somatic antigen via recombination.
There was divergence from this b-glucuronidase-positive
last common ancestor approximately 400 years ago with the
common ancestor of the current diversity appearing an esti-
mated 175 years ago. There are considered to be three main
lineages of EHEC O157 : H7, viz. I, I/II and II. The common
ancestor was lineage II, b-glucuronidase negative and sorbi-
tol non-fermenting. Lineage I split from this approximately
125 years ago and lineage I/II approximately 95 years ago
[3, 5].
KEY FEATURES AND DISCOVERIES
In 1983, Karmali et al. noted that Stx-producing E. coli may
be a common cause of haemorrhagic colitis preceding
haemolytic uraemic syndrome [6]. Stx is produced and
released following induction of the bacterial SOS response
which induces activation of the integrated Stx-encoding
prophage(s). As specific classes of antibiotics can induce
this response, there is debate over their use to treat EHEC
infections. Stxs share their catalytic mechanism with ricin
with an A subunit that arrests translation by depurination
of 28S rRNA as well as five B subunits involved in cell bind-
ing and trafficking. Globotriaosylceramide (Gb3/CD77)
toxin receptors are present on the surface of endothelial
cells throughout the human body, particularly capillaries in
the kidneys and brain. For intestinal colonization, E. coli
O157 :H7 forms ‘attaching and effacing’ lesions on intesti-
nal epithelia in a manner dependent on the T3SS encoded
by the locus of enterocyte effacement. Attaching and effac-
ing lesions are characterized by intimate bacterial adherence
to the apical surface of enterocytes on actin-rich ‘pedestals’
and destruction of proximal microvilli (Graphical abstract
figure). Remarkably, intimate adherence is facilitated by
injection of Tir, which serves as a receptor for the bacterial
outer membrane protein intimin [7]. Prototype E. coli
O157 :H7 strains inject around 40 ‘effector’ proteins,
expressed from the locus of enterocyte effacement and
assorted prophage regions, into enterocytes to subvert cellu-
lar responses [8].
Ruminants are a key reservoir of E. coli O157 : H7. Coloni-
zation of cattle is generally asymptomatic, as Gb3 is not
expressed on the surface of bovine endothelial cells. The
bacteria primarily colonize follicle-associated epithelium of
the terminal rectum and super-shedding animals are
responsible for the majority of on-farm transmission and
the threat of zoonosis [9]. The primary role of Stxs in reser-
voir hosts or the environment remains to be determined but
may include killing of grazing protozoa, immune modula-
tion and enhancement of bacterial adherence. Selection of
E. coli O157 : H7 in the bovine host may be towards innate
and adaptive immune silencing mechanisms that promote
persistence and transmission, whereas these mechanisms
may have different outcomes in humans as an incidental
host leading to life-threatening pathology.
Control measures have focused on the ruminant reservoir,
including vaccines based on secreted proteins or an extract
of iron-limited E. coli O157 :H7, but to date these have not
received sufficient uptake. Treatment in humans remains
largely supportive, with Stx-specific neutralizing antibody
and receptor mimics showing promise for control of sys-
temic sequelae in animal models. A serious outbreak in
2011 caused by an Stx2-producing E. coli O104 : H4 hybrid
with features of EHEC and enteroaggregative E. coli serves
to highlight the dynamic evolution of Stx-producing E. coli
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and compels us to look beyond E. coli O157 : H7 for future
threats.
KEY QUESTIONS
. What is the purpose of Stx in the environment and/or
ruminant host? Ultimately, the selective pressure main-
taining Stx also drives the evolution of EHEC strains
and so this knowledge is critical.
. What factors influence the zoonotic potential of EHEC
strains and disease severity? Despite the common pres-
ence of Stx-encoding E. coli in ruminants and the envi-
ronment, why do only a small subset of strains actually
cause serious human disease?
. What processes lead to the genetic convergence of mul-
tiple lambdoid prophages encoding both effector pro-
teins and Stx in strains with a T3SS, and how likely are
similar convergences with pathogenic potential?
. How do you generate an effective immune response
against an organism that manipulates host responses to
remain ‘under the radar’?
. What level of reduction of shedding in cattle is required
to reduce incidence of human disease? If only a small
subset of strains cause human disease, would widely
applied cattle-based interventions ever represent a cost-
effective method of controlling human infections?
Funding information
The authors received strategic institute core support from the BBSRC
(BB/J004227/1).
Acknowledgements
We acknowledge Dr Eliza Wolfson (http://lizawolfson.co.uk) for pro-
duction of the graphical summary.
Conflicts of interest
The authors declare that there are no conflicts of interest.
References
1. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol
Rev 1998;11:142–201.
2. Perna NT, Plunkett G, Burland V, Mau B, Glasner JD et al. Genome
sequence of enterohaemorrhagic Escherichia coli O157 : H7. Nature
2001;409:529–533.
3. Dallman TJ, Allison L, Gally DL, Wain J, Ashton PM et al. Applying
phylogenomics to understand the emergence of Shiga-toxin-pro-
ducing Escherichia coli O157 : H7 strains causing severe human dis-
ease in the UK. Microb Genom 2015;1:13.
4. Lupolova N, Dallman TJ, Matthews L, Bono JL, Gally DL. Support
vector machine applied to predict the zoonotic potential of E. coli
O157 cattle isolates. Proc Natl Acad Sci USA 2016;113:11312–
11317.
5. Feng P, Lampel KA, Karch H, Whittam TS. Genotypic and pheno-
typic changes in the emergence of Escherichia coli O157 : H7.
J Infect Dis 1998;177:1750–1753.
6. Karmali MA, Petric M, Steele BT, Lim C. Sporadic cases of hae-
molytic-uraemic syndrome associated with faecal cytotoxin and
cytotoxin-producing Escherichia coli in stools. Lancet 1983;321:
619–620.
7. Kenny B, Devinney R, Stein M, Reinscheid DJ, Frey EA et al.
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate
adherence into mammalian cells. Cell 1997;91:511–520.
8. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM et al. An exten-
sive repertoire of type III secretion effectors in Escherichia coli
O157 and the role of lambdoid phages in their dissemination. Proc
Natl Acad Sci USA 2006;103:14941–14946.
9. Matthews L, Low JC, Gally DL, Pearce MC, Mellor DJ et al. Hetero-
geneous shedding of Escherichia coli O157 in cattle and its implica-
tions for control. Proc Natl Acad Sci USA 2006;103:547–552.
Edited by: T. Parish
Five reasons to publish your next article with a
Microbiology Society journal
1. The Microbiology Society is a not-for-profit organization.
2. We offer fast and rigorous peer review – average time to
first decision is 4–6 weeks.
3. Our journals have a global readership with subscriptions
held in research institutions around the world.
4. 80% of our authors rate our submission process as
‘excellent’ or ‘very good’.
5. Your article will be published on an interactive journal
platform with advanced metrics.
Find out more and submit your article
at microbiologyresearch.org.
Gally and Stevens, Microbiology 2017;163:1–3
